Introduction
Rubella virus (RV) (family Togaviridae, genus Rubivirus) is a membrane-enveloped, positive-polarity ssRNA virus. The lipid membrane contains two transmembrane glycoproteins, E1 (Mr approx. 58000) and E2 (the heterogeneous glycosylation of which leads to a broad band of Mr 42K to 47K on SDS-PAGE) (Bowden & Westaway, 1984; Kalkkinen et al., 1984; Oker-Blom et al., 1983 , 1984 Waxham & Wolinsky, 1983) . This envelope surrounds a nucleocapsid consisting of the 9.8 kb (Dominguez et al., 1990 ) genome encased in a protein shell made up of a number of copies of the third structural protein, C (approx. Mr 34K) (Ho-Terry & Cohen, 1982; Oker-Blom et al., 1984; Waxham & Wolinsky, 1983) .
Although showing only very minor sequence homology to the alphaviruses (Dominguez et al., 1990) , RV has a similar replication strategy, in that the 5' end of the t Present address: Institute of Animal Health, Pirbright Laboratory, Ash Road, Pirbright, Woking, Surrey GU24 0NF, U.K.
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0001-0707 © 1992 SGM genome encodes non-structural proteins involved in the production of a negative-stranded intermediate (Hemphill et al., 1988) and the subsequent synthesis of both full-length copies of the genome and a 3.3 kb subgenomic RNA encoding the structural proteins . The structural proteins are synthesized as a polyprotein in the order NH2-C-E2-E1-CO2H (OkerBlom, 1984) ; cleavage of this polypeptide in vitro requires the presence of microsomal membranes (Clarke et al., 1987) , indicating that the C protein lacks the autoprotease activity of alphaviral capsid proteins; instead it is assumed that both of the required internal cleavages are executed by signal peptidase. Sequences fitting the signal sequence consensus (von Heijne, 1983) have been identified immediately preceding the N-terminal amino acids of E2 and E 1 ; these sequences have been shown to function as translocation signals in vitro and in vivo (Hobman & Gillam, 1989; Hobman et al., 1988) .
RV differs from alphaviruses in other ways. Its replication is slow, taking 12 to 16 h after infection before viral structural proteins can be detected intracellularly (Hemphill et al., 1988) , and without the shutoffof host protein synthesis exhibited by alphaviruses. In addition, although some authors have observed RV budding at the plasma membrane, particularly in BHK cells (Chatterji et al., 1969; Higashi, 1973; Murphy et al., 1968; Oshiro et al., 1969) , most others (even using the same cell line) have failed to see budding at the plasma membrane of the host cell, finding it rather at internal membranes, possibly of Golgi origin (Bardeletti et al., 1979; Bonissol & Sisman, 1968; Hamvas et al., 1969; Higashi, 1973; Kouri et al., 1974; McCombs et al., 1968 ; Tuchinda et al., 1966; von Bonsdorff & Vaheri, 1969) . The lipid composition of the virus (Bardeletti & Gautheron, 1976) lies midway between that of the endoplasmic reticulum (ER) and that of the plasma membrane (van Meer, 1989) , particularly with regard to the cholesterol/phospholipid molar ratio, again suggesting that the virus buds from an intracellular compartment.
We have recently shown (Suomalainen et al., 1990 ) that the RV C protein remains membrane-associated due to the presence of the hydrophobic E2 signal sequence at its C terminus. This could lead to nucleocapsid formation driving budding and virion formation at an early stage of the export pathway. Alternatively, the transmembrane glycoproteins E 1 and E2 might be specifically retained in an intracellular compartment, thereby constraining virion formation to occur intracellularly. It is therefore of considerable interest to investigate the synthesis and transport of these proteins in isolation from virion formation, to determine whether or not they reach the plasma membrane and, if not, to determine by what mechanism intracellular retention is achieved. In a recent study (Hobman et al., 1990) , immunofluorescence was used to show that E2 was transported to the surface of COS cells when expressed alone or with E 1, but that E1 required the presence of E2 for surface expression. This study, however, did not directly examine the proportion of E2 and E 1 located at the cell surface. The same report also suggested that the C protein was found in the cytoplasm, unless expressed with E2 and El. This result conflicted with our finding in vitro that the C protein is membrane-associated. To address these problems, and to elucidate further the intracellular processing and transport of C, E2 and El, we have expressed these proteins alone and in various combinations.
Methods
Plasmids. The full-length cDNA encoding the entire structural polyprotein of RV (RVS4) has been described (Suomalainen et al., 1990) . In the same paper we described the construction of plasmids pC, PC-ss, pE2 and pCE2, containing coding sequences for the capsid protein (C), the capsid protein without the membrane-anchoring E2 signal sequence(C_ss), the membrane protein E2, or the capsid protein followed by E2 (CE2), respectively. We made two additional constructs for the work described in this paper. (i) pE2E1. fragment from pE2 was joined to the 4307 bp PstI-EcoRI fragment from pRVS4 to create a construct encoding membrane proteins E2 and E1 preceded by an artificial signal sequence.
(ii) pE1. The 1483 bp PstIHindlll fragment from pRVS4 was subcloned into M13mpl8. Oligodirected mutagenesis (Suomalainen et al., 1990 ) was used to remove the remaining E2-encoding sequence and replace it with an artificial sequence similar to that used for pE2. The correct mutation was identified by sequencing and the EcoRI-HindlII fragment containing the whole E1 sequence was removed from mpl8 and cloned into pGEM3Zf(+). The resulting mutated sequences and their relationships to the normal RV-encoded protein sequence are shown in Fig. 1 . All constructs were first checked by in vitro transcription/translation (Suomalainen et al., 1990) to show that proteins of the correct size were being made, and that they were translocated into microsomal membranes (as seen from their acquisition of N-linked glycans) where appropriate. For in vivo expression, the EcoRI-HindlII fragments were isolated from the pGEM constructs and cloned into the plasmid pSVS (KondorKoch et al., 1983) by a three fragment ligation involving the coding sequence, the 3125 bp HindlII-AccI and the 535 bp AccI-EcoRI fragments from pSVSSFV. This placed the coding sequence immediately downstream from the simian virus 40 (SV40) early promoter and followed by the SV40 early poly(A) signals. This gave rise to the expression plasmids pSVSRVS4, pSVSCE2, pSVSE2E1, pSVSE2 and pSVSE 1. For some experiments, the RV constructs were inserted into a version of pEE7 (Stephens & Cockett, 1989) in which the order of EcoRI and HindllI sites had been reversed (pMSVL); in these constructs transcription was driven by the SV40 late promoter, leading to increased expression in COS cells. In this case the plasmids were termed pMSVLRVS4, etc. Note that both these vectors lack splice donor and acceptor signals; expression of the RV proteins was good in spite of this, possibly because these proteins are normally translated from cytoplasmically synthesized messages. Plasmid pSVTR has been described (Zerial et al., 1987) .
Recombinant vaccinia virus.
Recombinant viruses were made using the procedures described by Kieny et al. (H~inggi et al., 1986; Kieny et al., 1984) . HindlII-HindlII fragments from pSVS plasmids were cloned Transfection and infection. Transfections were performed using a modification of the method of Cullen (1987) . Briefly, 4.5 x 105 cells were plated 1 day before transfection on 35 mm dishes. 0.5 to 2 vtg of CsCl-banded plasmid was added to 200~tl 15 mM-NaPO4, pH 7-4, 150mM-NaCI (PBS), followed by 4~tl 25mg/ml DEAE-dextran (Pharmacia). Cells were washed once with PBS and then overlaid with the DNA mixture. [In some experiments 1 mM-Mg 2÷, 0.1 mM-Ca 2+ were added to the PBS (PBS-CM). This stopped the cells from detaching but slightly lowered the transfection efficiency.] Cells were incubated for 20 to 25 rain at 37 °C, and then 2 ml DMEM containing 100 ~tM-chloroquine (Sigma) was added to each dish. After a further 2.5 to 3 h at 37 °C, the cells were shocked for 3 min in 10~ DMSO (Merck) in DMEM, washed once with DMEM, and incubated for 40 to 44 h before labelling or immunofluorescence. For immunoftuorescence, cells were released from the dish with trypsin-EDTA at 24 h posttransfection and replated on glass coverslips. This tactic was employed because the cells became detached from glass during transfection.
COS cells were infected with RV as described for Vero cell infection (Suomalainen et al., 1990 Immunofluorescence. Transfected cells growing on glass coverslips were stained for immunofluorescence essentially as described (Timm et al., 1983) . The cells were opened for staining of internal proteins by incubating for 5 min in 0.5~ Triton X-100 in PBS, and were then stained with rabbit or mouse antibodies, followed by fluoresceinlabelled swine anti-rabbit Ig (Dakopatts) fluorescein-labeUed goat antimouse Ig or rhodamine-labelled sheep anti-mouse Ig (both from Biosys); the cells were finally washed and mounted. Photographs were taken on a Zeiss Axiophot microscope using Kodak T-MAX 3200 film.
Labelling oftransfected cells. Thirty-five mm dishes of transfected (or infected) cells were incubated for 30 min in 1 ml methionine-free MEM supplemented with 0-2~ bovine serum albumin (BSA). This was then replaced with 0.5 ml of the same medium containing 50 ~tCi [35S]methionine (SJ1515, Amersham) and incubation continued for a further 30 min. Cells were harvested immediately or incubated for different periods of time following the removal of the labelling medium and the addition of 2 ml complete DMEM. For long-term labelling of transfected COS cells, the cells were incubated for 12 h with 100 ~Ci [3sS]methionine in 1 ml MEM containing one-tenth the normal methionine concentration and supplemented with 3.5 g/l glucose, 0.2% BSA. Cells infected with recombinant vv were cultured for 5 h after infection and then incubated for 16 to 18 h in 0.7 ml methionine-free MEM-0.2% BSA containing 50 ~tCi [35S]-methionine and 10~ (v/v) normal medium for the cell line in question. For COS cells an additional supplement of 3.5 g/l glucose was added.
Cells were harvested by washing three times with PBS-CM and solubilizing in 0.5 ml lysis buffer (1 ~ NP40, 400 mM-NaCI, 5 mM-EDTA, 50 mM-sodium phosphate buffer pH 7.4, 10 mM-ATP, 20 ftg/ml PMSF) for 5 min on ice. The lysate was then centrifuged at 18000 r.p.m, for 2 h in a Beckman JAI8.1 rotor, and the supernatant incubated with 1 ~tl non-immune rabbit serum and 20 ~tl Protein A Sepharose (Pharmacia) for 2 to 16 h at 4 °C. After removal of the Sepharose, the supernatant was then extracted with rabbit anti-RV (the kind gift of Professor R. Petersson, Ludwig Institute for Cancer Research, Stockholm, Sweden), various monoclonal anti-C, E2 or E1 antibodies (the kind gift of Professor J. Wolinsky, University of Texas Health Sciences Centre, Houston, Tx., U.S.A.) or OKT9 monoclonal anti-human transferrin receptor antibody. Immune complexes were collected on Protein A-Sepharose, with 1 ~tl rabbit anti-mouse IgG (Dakopatts) where appropriate. Sepharose pellets were washed and prepared for SDS-PAGE as previously described .
Gel electrophoresis. SDS-PAGE was performed using the buffer system of Laemmli (1970) . Gels were fluorographed using sodium salicylate (Chamberlain, 1979) .
Radiosequencing. Transfected cells were labelled as described above, except that the labelling was in leucine-free MEM and cells were incubated for 2.5 h with 100 ~tCi [3H]leucine (TRK170, Amersham). Labelled proteins were isolated with monoclonal anti-E2 or anti-E1 antibodies and released from the Protein A-Sepharose by heating at 95 °C in 0.5 ~ SDS. One half of each was then analysed by SDS-PAGE and the other half was sequenced on an Applied Biosystems 470A sequencer. Half the output from each sequencer cycle was taken for determination of 3H d.p.m.
Biotinylation of cells.
Cells were labelled with sulphosuccinimidyl 6-(biotinamido) hexanoate (SBH) (Pierce Chemicals) essentially as described (Graeve et al., 1990) . The cells were washed four times in PBS-CM at 4°C and biotinylated for 20 min at 4°C in 1 ml of 0.5 mg/ml SBH in PBS-CM. The biotinylation was repeated once, and the cells were washed twice for 5 min in DMEM. The cells were lysed in 0.5 ml lysis buffer containing 50 mM-lysine. (Where total biotinylation was determined, the cells were washed and lysed as for pulse~hase studies, the lysate was centrifuged for 10 min at 14000 r.p.m, to remove nuclei, and SBH was added to a final concentration of 1 mg/ml. After 40 min at 4 °C, the solution was made 50 mM in lysine and incubated for 10 min at 20 °C.) Lysates were cleared and immunoextracted as above. The immunoprecipitated proteins were released from Protein ASepharose by heating three times for 2 min at 95 °C in 100 ~tl 1 ~ SDS, vortexing between each 2 min (control experiments showed that subsequent extraction of the Sepharose with complete SDS-PAGE sample buffer did not release any more protein). To the 200 ~tl of eluate were added 50 Ill 10 x PBS, 60 ~tl 10~ NP40, and 290 lal H20; the total immunoprecipitate was then extracted with 25 ttl streptavidin-agarose (Sigma) for 2 h at 4 °C (again, controls showed that no further protein could be adsorbed by a second round of extraction with streptavidinagarose). The streptavidin-agarose was washed in the same way as were immunoprecipitates, and the bound proteins were eluted with SDS-PAGE sample buffer. Unbound proteins were precipitated with TCA using a detergent carrier (Bartles et al., 1985) , and dissolved in SDS-PAGE sample buffer.
Membrane association assay.
For studies of membrane association of the C protein, 6 cm plates of COS cells were transfected with pMSVLCE2, pMSVLC or pMSVLC_ss. The cells were labelled for 30 min, about 40 h after transfection. After labelling, the cells were transferred to ice, washed three times with ice-cold PBS, resupended in isotonic sucrose and homogenized with 20 strokes of a tight-fitting Dounce homogenizer. Nuclei and associated membranes were removed by centrifugation at 5000 r.p.m, for 5 min. Fractions of the supernatant (crude microsomes) were adjusted to physiological salt (NS) or high pH (Bit) as described (Suomalainen et aL, 1990) , incubated for 20 min on ice, then centrifuged for 2-5 h at 16500 r.p.m. The supernatants were adjusted to neutral pH (where necessary) and 0.5 ~ (v/v) NP40, and the pellets dissolved in lysis buffer. The C protein was immunoprecipitated from each fraction as described above and analysed by SDS-PAGE.
Lectin-binding assays. The acquisition of galactose residues as a marker of passage of proteins to the Golgi complex was measured by determining the amount of each protein that was bound to Ricinus communis agglutinin (RCA12o)-agarose (Sigma). Proteins were immunoprecipitated as normal, and released from the antibody-Protein A-Sepharose by heating for 5 min at 95 °C in 100 I111 ~ (w/v) SDS. The supernatant was removed, the pellet rinsed with 400 ~tl 1.5% NP40, 1.25 x PBS and the wash was added to the SDS solution. This solution was then incubated for 18 h at 4 °C with 30 I11 RCA12o-agarose. The agarose was spun down, washed as for immunoprecipitates and the bound glycoprotein eluted with sample buffer. Unbound material was recovered by precipitation with TCA as described above. Bound and unbound fractions were then analysed by SDS-PAGE. The presence of O-linked glycans was determined by using a 1 ml column of Jacalinagarose (Vector Laboratories). Radiolabelled RV was solubilized by heating in 0.5% SDS to separate E2-EI dimers; the sample was then diluted fivefold and NP40 added to 0-6%. The viral proteins were loaded onto the column, which had been equilibrated with 175 mMTris-HCl, pH 7.5, 0.1% NP40. The column was washed with 10 x 1 ml of this buffer, then eluted with 5 x 1 ml of the same buffer containing 0.8 M-galactose.
Preparation of antiserum to the E2 C-terminal sequence. The 12 amino acids immediately preceding the N terminus of E1 (VVLQGYNP-PAYG) were expressed as a C-terminal fusion with the maltosebinding protein (di Guan et al., 1988) using the vector pPR681 (the kind gift ofP. Riggs, New England Biolabs) which had been modified (P. Liljestr6m & S. Lusa, unpublished results) to insert an EcoRI site downstream of the BamHI site in the polylinker. A pair of oligonucleotides were made which, when hybridized, gave BamHl-and EcoRI-compatible ends. When ligated between the BamHI and EcoRI sites of the vector the resulting sequence created an in-frame fusion of the E2 sequence to the maltose-binding protein, followed by a translation stop codon (TGA). Codons were chosen based on E. coli codon usage (Maruyama et al., 1986) . The sequence was checked by sequencing the plasmid. The fusion protein was expressed in E. coli DH5ct; it was largely secreted into the periplasmic space, where it made up about 60% of the protein, as judged by Coomassie blue staining after SDS-PAGE. A crude periplasmic fraction was prepared by cold osmotic shock (Neu & Heppel, 1965) , denatured by heating at 80 °C for l0 min, and used to immunize New Zealand White rabbits by intramuscular injection. Two-hundred ~tg of protein was used per injection as an emulsion with Freund's complete (first injection) or incomplete (subsequent boosts) adjuvant.
Results

Synthesis o f R V proteins from c D N A constructs
To express the individual RV structural proteins separately we had to construct coding units for E2 and E1 with new translation start sites and, for E2, a stop codon. In addition, the two glycoproteins had to be provided with signal sequences to ensure translocation across the E R m e m b r a n e , as happens with the viral proteins. These constructs (described in Methods) were initially made in p G E M vectors which allowed us to synthesize R N A in vitro a n d translate it in rabbit reticulocyte lysates to check that the proteins were being m a d e to the correct size. It was clear from these in vitro translations that the signal sequences functioned to induce translocation, and hence glycosylation, of the following peptide sequence (not shown). W h e n pSVS or p M S V L versions of these constructs were transfected into COS cells, proteins of the same size as those found in RV-infected cells could be precipitated with a n t i -R V serum or specific monoclonal antibodies (Fig. 2) , showing that the proteins were synthesized, translocated a n d glycosylated in a way that was indistinguishable from those in RV-infected cells. We had used artificial ' o p t i m i z e d ' signal sequences in order to eliminate any problems due to the fact that the n o r m a l E2 and E1 signal sequences are designed to function from inside a long polypeptide, rather t h a n at the N terminus. It was therefore i m p o r t a n t to establish that cleavage of the introduced signal from the m a i n protein was occurring, a n d at the right position. We i m m u n o p r e c i p i t a t e d E1 a n d E2 from transfected COS cells that had been labelled with [3H]leucine. The resultant proteins were processed on a protein sequencer, and the sequencer cycles at which 3H was released were d e t e r m i n e d (Fig. 3) . As c a n be seen, in each case the peak of 3H appeared exactly in the cycle predicted when cleavage of the signal sequence was occurring properly. Note that the anti-E1 a n t i b o d y used also precipitates the E l -E 2 heterodimer that forms w h e n these proteins are 6^. ,(a) co-expressed (Baron & Forsell, 1991) . This resulted in the co-precipitation of a small amount of E2 with the E1 from pSVSRVS4-transfected cells, which in turn resulted in a small peak of 3H in cycle 2 of this material, corresponding to the leucine at position 2 in E2. This was followed by the main E 1-derived leucine peak at cycle 7. It should be noted that, while this manuscript was in preparation, Frey and co-workers published data showing that the normal E2 signal (C protein anchor) could function as an external signal sequence as well as an internal one, both in vitro (Marr et al., 1991) and in vivo . It has been suggested (Nakhasi et al., 1986 ) that the C terminus of E2, including the E1 signal sequence, is removed from E2 due to the cluster of Arg residues that follow the E2 membrane anchor. To clarify this point, and to confirm the authenticity of E2 produced from our constructs, we prepared an antiserum directed against the extreme C terminus of the El signal sequence (see Methods). This antiserum precipitated E2 from labelled -4) or pulse-labelled RVinfected ceils (lanes 5 to 8) were lysed and proteins precipitated with preimmune anti-E2ct (lanes 1 and 5), anti-E2ct (lanes 2 and 6), rabbit anti-RV (lanes 3 and 7) or monoclonal anti-E2 (lanes 4 and 8). Note that this monoclonal antibody does not recognize the viral form of E2.
virus and labelled infected cells (Fig. 4) , as well as from pSVSE2-and pSVSE2El-transfected cells (data not shown), thereby showing clearly that this sequence is not normally removed from E2. From all these data we deduced that our constructs express authentic E2 and E 1 proteins. In addition, the synthesis and degradation of these proteins was studied using pulse-chase analyses, comparing them with the same proteins synthesized during RV infection; no difference was seen in the halflives of RV proteins expressed from c D N A or from virus (data not shown).
Localization of the C protein
We have previously shown (Suomalainen et al., 1990) that the translocation signal for E2 remains attached to the native C protein, and that this leads to the C protein being membrane-associated in in vitro studies. We have extended this work to expression in whole cells, and studied the localization and membrane association of the C protein when expressed with and without the E2 signal sequence (C and C-ss) as well as with E2 (CE2) or both E2 and E1 (RVS4). In order to study the membrane association, COS cells were transfected with pMSVLCE2, pMSVLC or pMSVLC_ss. Control studies showed that the C protein in each case dimerized as does the normal viral protein (Baron & Forsell, 1991) , and that the turnover rates of C (with or without E2) and C-ss were indistinguishable (data not shown). Membrane association was studied by pulse-labelling transfected cells with [35S]methionine, preparing a post-nuclear supernatant (cytoplasm plus microsomes), and treating that supernatant with high pH. Under these conditions, integral membrane proteins remain membrane-associated, whereas peripheral proteins, or proteins contained within vesicles, are released (Bendzko et al., 1982; Howell & Palade, 1982) . Previously we have found that C, but not C-ss, remains partly membrane-associated even after high pH extraction, when expressed in vitro in the presence of canine The post-nuclear supernatant was prepared and treated with 0.15 M-KCI (NS) or 0-1 M-NazCO3, pH 11.2 (Bic) as described in Methods. After centrifugation to separate membrane (P) and cytoplasm (S) fractions, the C protein in each fraction was immunoprecipitated with monoclonal anti-C antibody. In addition the E2 protein from pMSVLE2-transfected cells was immunoprecipitated with anti-E2ct (right-hand panel). The precipitated proteins were analysed by SDS-PAGE and fluorography.
pancreatic microsomes. This association was strongest when the C protein was expressed as CE2, so that the signal sequence would be inserted into the membrane during the translocation process. When expressed in COS cells, the C protein of CE2 showed this association (Fig. 5) ; as found previously, it was not as complete as that of E2 (Fig. 5) . C-ss, as expected, was found almost entirely in the soluble fraction, even at physiological pH. C protein expressed from pMSVLC was intermediate, about half pelleting with the membrane fraction under normal salt conditions, and part of this dissociated from the membrane by high pH. This confirms our in vitro finding that C, but not C_ss, can post-translationally associate with membranes, but that this association is peripheral, and not as strong as when the E2 signal is involved in the translocation of E2 across the bilayer. Immunofluorescence studies showed that, in pMSVLRVS4-transfected cells, C and E2 were both found in a perinuclear location resembling the Golgi complex (Fig. 6a, b) . In cells expressing CE2, the proteins were again both concentrated in this region, although E2 was now sometimes found more widely distributed in the cell (Fig. 6c, d ). If C was expressed on its own it was found in a reticular structure extending throughout the cell, probably the ER (Fig. 6e) . The perinuclear location of C was not restored by expressing C and E2 in the same cell from separate coding units. Fig. 6(g, h) shows the result of cotransfecting COS cells with pMSVLC and pMSVLE2. E2 is again found in both ER and Golgi, but C is found only in the ER. Surprisingly, when C_s~ was expressed in cells, it was not found distributed throughout the cytoplasm, as might be expected for a soluble protein, but in a discrete, punctate pattern, often in small groups (Fig. 6f) . The nature of these groups remains to be elucidated. Since the tail-less C dimerizes normally, it is possible that higher order structures are forming.
E2 and E1 are transported to the surface when co-expressed
The primary question to be answered concerning the RV glycoproteins was whether they come to the surface of the cell. If they do not, then virus maturation would be restricted to interior membranes; if they do, some other cause must be found for the intracellular budding of the virus. We decided to apply a biochemical procedure to measure the amount of these proteins at the cell surface, since we lacked monospecific antibodies to E2 that were not limited to a particular epitope and, in any event, immunofluorescence measurements would not be quantitative. We therefore applied the technique of surface biotinylation used extensively in studies of surface transport in epithelial cells (Br/indli & Simons, 1989; Graeve et al., 1989 Graeve et al., , 1990 Lisanti et al., 1988 Lisanti et al., , 1989 Lisanti & Rodriguez-Boulan, 1990; Matter et al., 1990; Sargiacomo et al., 1989) . In this assay, cell surface proteins are detected by treatment of the cells with a membrane-impermeant amino-reactive derivative of biotin (see Methods). Specific proteins were immunoprecipitated and the biotinylated (surface) proteins separated from non-biotmylated (internal) by binding to streptavidin-agarose. Originally we attempted to follow the appearance of pulse-labelled proteins at the surface during a chase period. Although TR could be followed to the surface of pSVTR-transfected cells, no RV-specific proteins could be detected at the surface of pSVSRVS4- transfected cells even after 6 h of chase (data not shown). Control experiments showed that biotinylation was equally effective as trypsinization at detecting cell surface TR, at least, and that the RV proteins were fully accessible to the biotinylating reagent if the cells had been lysed before addition of the reagent (data not shown), indicating that the failure to biotinylate the RV proteins was due to their absence from the surface. It was possible, however, that the pulse-labelled RV proteins came to the surface gradually, not as a single cohort, and were then internalized. This would mean that there might never be a sufficient fraction of the labelled proteins at the surface to be detected. We therefore labelled cell proteins over a long period, so that the radiolabelled proteins would reflect the state of the whole population of proteins. In this way the biotinylation assay should involve the same population of proteins as an immunofluorescence study. We also wished to examine the transport of these proteins in the fibroblast cell lines that are normal hosts for RV, rather than only in COS cells, which are transformed cells and in which transport kinetics are slower than in normal fibroblasts (Lazarovits et al., 1990) . We therefore sought an expression system with a wider host range. Recombinant vv expressing a wide variety of viral proteins have been constructed. In all cases the transport of the expressed proteins has been normal [reviewed in Moss & Flexner (1987) ], including correct vectorial targeting of proteins in polarized cells (Stephens et al., 1986) . In addition, although infected ~ells show extensive c.p.e., cell lysis does not occur (B. Moss, personal communication) . Since vv will infect a very wide range of hosts, this system seemed a good one to examine the synthesis and transport of the RV proteins in cell lines normally used for culturing RV. We therefore prepared recombinant vv expressing the various constructs and used these to express the RV proteins in RK13 ceils, BHK cells and B-Vero ceils, all lines frequently used for studies on RV. We also infected COS cells for comparison with the transfected cell system, and to be sure that no change of distribution of expressed proteins resulted from c.p.e.
After overnight labelling of cells infected with recombinant vv, surface-accessible proteins were biotinylated and isolated by using streptavidin-agarose. The results of these studies are shown in Fig. 7 . Surface TR, our control protein, could be detected easily in all four cell lines; the fraction on the surface agreed with previous estimates (Bleil & Bretscher, 1982; Lamb et al., 1983) of 20~ to 30~ surface TR. The exception was the B-Vero cells, which showed poor surface expression of any protein. E 1, expressed alone, could not be detected at the surface in any cell line. When expressed on its own, or with the C protein, a small fraction of E2 could be biotinylated on B-Vero cells and on RK13 cells; further exposure of the fluorographs showed similar trace amounts of E2 at the surface of COS and BHK cells. Coexpression of E2 and El, either from vvE2E1 or by coinfection with vvE2 and vvE1, led to surface expression of both proteins, clearly in BHK and RK13 cells, to a lesser extent in B-Vero and COS cells. The fraction of E1 or E2 at the surface was, in all cases, very low, suggesting that the major fraction of both proteins is retained inside the cell. No difference was found between transfected and vv-infected COS cells with any of the constructs used in these studies (data not shown), showing that vv infection had not been the cause of the intracellular retention.
E2 is required for transport of E1 to the Golgi apparatus but not vice versa
In these studies, we observed that conversion of E2 from the initially synthesized form (E2i) to the viral form [E2v: characterized by a broad 'smear' appearance in SDS-PAGE (Fig. 7) ] seemed to require the presence of El, since this 'smear' could always be detected in vvRVS4-, vvE2E1-and vvE2 + vvE 1-infected cells, but not in cells infected only with vvE2. We have observed that inhibition of N-linked glycan processing with deoxymannojirimycin prevents the conversion of E2i to E2v (M.D. Baron & K.F. Forsell, unpublished results) . Since the processing of such glycans occurs in the Golgi, a requirement for E1 for the conversion of E2 would imply a requirement for E1 for E2 transport from the ER to the Golgi complex. This would fit well with the observation that E2 and E1 form heterodimers (Baron & Forsell, 1991) . Alternatively, it might only be the heterogeneity of processing that is a consequence of dimerization, and E2 could be transported on its own. It was therefore important to use other markers for transport to the Golgi complex than the conversion of E2 to E2v. In addition, it was of equal interest to see whether E1 could be found in the Golgi in the absence of E2.
We therefore examined the glycan chains of E 1 and E2 when expressed alone or together for signs of Golgi modifications. Although there are many possible modifications to N-linked glycan chains in this organelle, in most cases at least one galactose or an N-acetyl galactosamine residue is added. This takes place even when the resultant glycan is not resistant to digestion with endoglycosidase H, as is the case for certain types of hybrid N-linked glycans (Maley et al., 1989) . It has previously been shown (Toivonen et al., 1983 ) that both E1 and E2 from RV bind RCA12o, a lectin which binds primarily/~-D-galactose (Baenziger & Fiete, 1979) . We immunoprecipitated E1 and E2 from cells infected with vvE2, vvE1, vvE2E1 or with both vvE2 and vvE1, and extracted the immunoprecipitates with RCA120-agarose to determine whether the proteins acquired galactose (Fig. 8) (only a small fraction of E2 or E1 bound to the column in these experiments, but this seems to be a reflection of the low capacity of the lectin; re-extraction of the 'unbound' fraction with RCA120-agarose yielded results identical to those of the first extraction). The heterogeneously processed fraction of E2 was efficiently bound by the lectin; by moving the E2v form from the background of E2i, it was also possible to see that some E2 was processed even in the absence of E 1, although E 1 improved the efficiency of E2 conversion (compare Fig.  8 a, lanes 4 and 8 with lane 12; this is perhaps more easily seen in Fig. 8 b, in which the lectin-bound fractions have been run side-by-side on the same gel). It is clear from this experiment that E1 showed a time-dependent increase in binding to RCA120-agarose only if it was expressed in the presence of E2. Hence, E1 requires E2 for transport to the Golgi complex, but E2 does not require E 1, although the rate of transport of E2 appears to be increased in the presence of El. It is also clear that the heterogeneous processing of the glycans on E2 is a function neither of virion formation nor of the heterodimer, but only of the E2 protein itself.
A fraction of unprocessed E2 bound to the lectin even at zero chase time, whether the proteins were expressed alone or together; this fraction did not increase with further incubation. The presence of O-linked glycans is the most likely explanation of this binding of E2 at early time points. RCA12 0 binds the core disaccharide of Olinked glycans (galactose-fl-l-3-N-acetyl galactosamine) well, and also the initial N-acetyl galactosamine, albeit 2), vvRVS4 (3, 4), vvCE2 (5, 6), vvE2E1 (7, 8), vvE2 (9, 10), vvE1 (11, 12) or both vvE2 and vvE1 (13, 14) . The cells were labelled and biotinylated as described under Methods and the immunoprecipitated proteins separated into non-biotinylated (odd-numbered lanes) and biotinylated (even-numbered lanes) by incubation with streptavidin-agarose. The labelled proteins were separated by SDS-PAGE and the gel was fluorographed. poorly (Baenziger & Fiete, 1979) . The initial sugar of Olinked glycans is added in the ER (Pathak et al., 1988; Tooze et al., 1988) . It has recently been shown that E2, but not E 1, contains O-linked glycans (Lundstr6m et al., 1991 ; ; in agreement with this, we found that E2, but not E 1, bound to the O-glycan-specific lectin Jacalin (not shown). These biochemical data are confirmed, to some extent, by immunofluorescence studies of the location of the RV structural proteins when expressed in various combina- tions. These suggest that E2 and E1 co-localize in a Golgi-like compartment in COS cells when expressed together, with or without the C protein (Hobman et al., 1990 ; our own unpublished observations). In addition, E2, when expressed alone, was found distributed in both the ER and the Golgi complex (Hobman et al., 1990 ; our own unpublished observations). However, the absence of Golgi-specific processing of E1 if this protein is expressed without E2 is at odds with the reported location of E 1 in the Golgi in such cells (Hobman et al., 1990) . In our immunofluorescence studies we observed El, expressed on its own, in large vesicular structures either distributed in the cytoplasm (Fig. 9a ) or in a perinuclear location (Fig. 9b ). These structures are clearly different from the reticular Golgi complex seen in these and other studies using COS cells (Fig. 6a, b ). Simultaneous labelling with an antibody against the 58K intermediate compartment/cis-Golgi-specific protein (p58) (Saraste et al., 1987; Saraste & Svensson, unpublished results) showed that these structures contained large amounts of this protein (Fig. 9c, d ). The El and p58 co-localized whether the vesicles were peripheral or perinuclear.
Discussion
We have engineered the coding sequence for the structural polyprotein of RV in such a way that the three structural proteins, C, E2 and El, could be expressed separately and together. We have used these constructs to study the intracellular distribution and transport of the structural proteins in the absence of virion formation.
In accord with our earlier in vitro studies (Suomalainen et al., 1990) we found that the C protein was membraneassociated, and this association was at least partly resistant to a high pH (bicarbonate) wash. In similar experiments we have found also that the C protein remains partly membrane-associated after a 0-8 M-KC1 wash (data not shown). In cells expressing C alone, the C protein was found only in the ER. In ceils expressing the entire structural polyprotein or the CE2 construct, however, C protein was found with E2 (and El) in the Golgi complex. This might suggest that the RV C protein is capable of direct interaction with E2 or with the E2-E 1 heterodimer, leading to its cotransport out of the ER into the Golgi. However, when C and E2 were coexpressed from separate plasmids, the C protein remained in the ER. These data suggest that the concentration of C in the Golgi depends primarily on the cotranslational insertion of the carboxy terminus of the protein into the membrane when it acts as the signal sequence for E2. Further work will be required to clarify this point.
When a modified version of the C protein lacking the normal hydrophobic carboxy terminus (C-ss) was expressed in cells, it did not cosediment with microsomal membranes, indicating that it was behaving as a soluble protein and confirming that the membrane association of the normal C protein was due to this hydrophobic sequence. Immunofluorescence studies revealed that the mutant C protein was present in the cells as discrete bodies and clusters of bodies; the C_s~ protein appears to dimerize as normal, and it is possible that it is also forming larger aggregates, or associating with other, as yet unidentified subcellular structures. GiUam and coworkers (Hobman et al., 1990; McDonald et al., 1991) have reported that the normal C is distributed throughout the cytoplasm, with or without the E2 protein. It is difficult to explain these findings in the light of both our own immunofluoresence studies and the results of our in vitro and in vivo membrane association assays.
When expressed alone, the E1 protein was never detected at the cell surface. Immunofluorescence studies in COS cells showed that E 1 was concentrated in large vesicular structures, sometimes located near the Golgi complex, and analysis of modifications to N-linked glycans showed that El did not reach the medial Golgi if not expressed with E2. The structures in which E1 accumulated contained large amounts of a 58K protein that is found only in the cis-Golgi or the intermediate compartment (Saraste et al., 1987; Saraste & Svensson, unpublished results) . Since the E 1-containing structures were both peripheral and perinuclear, and did not co-localize with WGA when peripheral, it is more likely that they are derived from the intermediate compartment. E 1 is acylated, even when expressed alone (Hobman et al., 1990) , showing that it reaches the functionally late ER or the intermediate compartment (Schmidt & Schlesinger, 1980) which is in agreement with our localization to the latter compartment. We have shown that E1 and E2 normally form a heterodimer and that, in the absence of E2, E1 is slowly converted to a high Mr aggregate (Baron & Forsell, 1991) . These data are in accord with the idea that E1 is unstable in the absence of its normal dimerization partner, and forms aggregates which accumulate in intracellular vesicles, either in the late ER or removed from the secretory pathway. Hobman et al. (1990) have reported that El, when expressed alone, was transported to the Golgi complex. However they also failed to show processing of E1 glycans under these conditions. In many Elexpressing ceils, especially multinucleate, possibly dividing cells, the El-containing vesicles accumulate in a Golgi-like region, despite having a different structure, and this may have led to the difference in our findings.
When E2 and E1 were expressed together (with or without the C protein), both glycoproteins were detected at the surface. Nevertheless, separation of surface (biotinylated) from internal (non-biotinylated) proteins showed that the majority of the glycoproteins were retained inside the cell, whilst immunofluoresecence has shown that the proteins accumulate in the Golgi complex. The intracellular budding of RV is therefore likely to be the result of intracellular retention of the glycoproteins. The mechanism of this retention has yet to be determined. For two other viruses which mature at intracellular membranes, avian infectious bronchitis virus (IBV) and adenovirus, specific retention signals have been found on structural proteins which are absolutely retained in the subcellular compartment in question, ER for the adenovirus El9 protein (Jackson et al., 1990; P/i/ibo et al., 1987) and the intermediate compartment for the IBV E1 protein (Machamer & Rose, 1987; Machamer et al., 1990) . The intracellular retention of the RV structural proteins appears to be of a different type, since the surface expression of the RV E2-E1 heterodimer shows that neither protein has a dominant retention signal; indeed, the concentration of the proteins in the Golgi seems to require the formation of the heterodimer. Further work will be needed to clarify the mechanism which inhibits the onward transport of these proteins.
It is apparent that E 1 cannot reach the Golgi complex unless as a heterodimer with E2, as previously shown for the E1 protein of Semliki Forest virus (SFV) (KondorKoch et al., 1982; Lobigs et al., 1990) . The amount of E2 transported through the Golgi complex and to the plasma membrane varied considerably between different cell lines, with RK13 cells appearing tobe the most permissive of transport, and COS cells the least, of the four types of cell studied here. A similar difference was seen for the surface expression of the E2-E1 heterodimer. It is not clear why some cells should be more permissive of transport than others; however, it is not possible to ascribe the variant reports in the literature as to the site of RV budding to the same cause as our observations of cell line variation in transport of RV proteins. Of the four lines in our study, BHK and RK13 cells allowed the most transport of E1 and E2 to the surface, yet the latter cell line has been consistently reported as showing only intracellular budding (Hamvas et al., 1969; Higashi, 1973; Holmes et al., 1968; Patrizi & Middlekamp, 1970) . On the other hand, RV-infected RK13 cells form syncytia, suggesting that the viral fusion protein, at least, is found at the cell surface (Patrizi & Middlekamp, 1970) . BHK cells have been reported to show predominantly (Murphy et al., 1968) , partly (Bardeletti et al., 1979; Higashi, 1973; Oshiro et al., 1969; von Bonsdorff and Vaheri, 1969) or no (Edwards et al., 1969; Tuchinda et al., 1966) budding from the plasma membrane. RV budding in the Vero cell line has been reported to be intracellular (Tuchinda et al., 1966) or at the plasma membrane (Payment et al., 1975) ; expression of RV proteins from recombinant vv in Vero cells showed either no detectable surface E2 or E1 (A. Sanchez & T. Frey, personal communication) or very little (the studies reported here). What is apparent from these earlier reports is that very widely differing m.o.i.s were used, and infected cells were examined at very different times post-infection. It is therefore conceivable that, if different cell lines can differ in the tightness with which they control intracellular transport of certain proteins due to differences in the amount of some cellular factor(s), the amount of this factor may also vary during the course of a viral infection, and/or with the degree of initial infection; this would, in turn, lead to changes in the retention of RV.
Finally, in the course of these studies, we have found that the E2 protein contains O-linked glycans, confirming other recent reports (Lundstr6m et al., 1991 ; . The presence of O-linked glycans reconciles two previously contradictory reports which showed that the N-linked glycans of RV did not contain sialic acid (Bowden & Westaway, 1985) and that the mobility of the E2 protein on SDS-PAGE gels was increased by treatment with neuraminidase (Oker-Blom et al., 1983) ; the latter results could be accounted for by the removal of sialic acids from O-linked glycans.
